Penobscot Investment Management Company, Inc. Eli Lilly & CO Transaction History
Penobscot Investment Management Company, Inc.
- $1.27 Billion
- Q3 2025
A detailed history of Penobscot Investment Management Company, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Penobscot Investment Management Company, Inc. holds 11,945 shares of LLY stock, worth $10.1 Million. This represents 0.72% of its overall portfolio holdings.
Number of Shares
11,945
Previous 10,436
14.46%
Holding current value
$10.1 Million
Previous $8.14 Million
12.03%
% of portfolio
0.72%
Previous 0.71%
Shares
13 transactions
Others Institutions Holding LLY
# of Institutions
4,470Shares Held
780MCall Options Held
16.5MPut Options Held
12.3M-
Lilly Endowment Inc Indianapolis, IN95.5MShares$80.6 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA80.4MShares$67.9 Billion1.05% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$55.6 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.3MShares$43.3 Billion26.07% of portfolio
-
State Street Corp Boston, MA34.5MShares$29.1 Billion1.04% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $802B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...